FOS and acute myeloid leukemia: Staber et al. (9) claimed that the expression of c-Jun and c-Fos in the transcriptional level was enhanced in relapsed AML over untreated patients, indicating that the AP-1 family is associated with poor prognosis, while the mechanism of other AP-1 components, such as FosB, has not been investigated in AML.